Rick Doblin of MAPS Talks Medical Cannabis Trials and a Possible Legalization TimelineThere may be no one in America who cares more deeply about the end of cannabis prohibition than Dr. After going through such a frustrating experience, how did your strategy evolve for getting government approval for medical cannabis research? Did you have any success trying to do medical marijuana research in the 1990s? After 1996, when California and Arizona passed medical marijuana, NIDA was aware that part of the argument for wanting to pass medical marijuana laws was that there was no way through the FDA. It was blocked, politically. You’ll get different answers on this depending on who you talk to, but medical marijuana initiatives do much better in presidential election years.
Health Cannabis health information including its use as a treatment for ailments and safety considerations.
Rick Doblin of MAPS Talks Medical Cannabis Trials and a Possible Legalization Timeline
There may be no one in America who cares more deeply about the end of cannabis prohibition than Dr. Rick Doblin. Since 1986, he has been executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit running FDA-approved clinical trials to study the medical efficacy of Schedule I controlled substances such as cannabis and MDMA.
Due to the remarkable success of their Phase II studies, MAPS recently received FDA approval to conduct large-scale, Phase III clinical trials for MDMA-assisted psychotherapy for treating post-traumatic stress disorder (PTSD). MAPS has also received FDA approval to study the safety and efficacy of medical cannabis in treating symptoms of PTSD. Gaining government approval for these studies is no easy task—the...
Read the full article @ Leafly